Nexstim, established 2000, is commercializing a revolutionary brain scanning technology, focusing initially on significant opportunities in neurodiagnostics with the potential to enter vast future markets for neurotherapy applications. The company’s transcranial magnetic stimulation (TMS) technology is safe and non-invasive, with relatively low thresholds for regulatory approval and clinical adoption. Nexstim has a solid intellectual property position and a significant body of research validation. The business model is geared to high growth and high value creation. Nexstim is ISO certified, products are CE marked and the company is pursuing 510 K approval during 2008.

Speaker Profile

Mr.Jukka-Pekka Särkkä, CEO

Mr.Jukka-Pekka Särkkä, CEO who joined Nexstim end of 2005 , has more than 20 years experience in international medical technology research, business development and business leadership. Mr.Särkkä has made his international career both in large and small organisations. He joined Nexstim from GE Healthcare Helsinki(former Instrumentarium Corp) where he has held various managerial and leadership positions both in Europe and USA.